Announcements Trials

Browse Landscape

Phase

Status

Completed 63 Unknown 17 Recruiting 14 Withdrawn 3 Terminated 3 Not yet recruiting 3 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 35 Breast Neoplasms 30 Prostatic Neoplasms 22 Leukemia, Myeloid, Acute 20 Colorectal Neoplasms 20 Melanoma 17 Pancreatic Neoplasms 16 Glioblastoma 16 Carcinoma, Non-Small-Cell Lung 16 Neoplasm Metastasis 15 Lung Neoplasms 13 Brain Neoplasms 13 Glioma 12 Stomach Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 11 Carcinoma, Hepatocellular 11 Ovarian Neoplasms 10 Multiple Myeloma 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Lymphoma 8 Carcinoma, Renal Cell 8 Leukemia 7 Sarcoma 6 Rectal Neoplasms 6 Hematologic Neoplasms 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Recurrence 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Warts × Clear all

NCT01796795 2023-09-14

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

G&E Herbal Biotechnology Co., LTD

Phase 2 Suspended

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡